Back to Search
Start Over
Novel advances in biotransformation and bioactivation research – 2020 year in review
- Source :
- Drug Metabolism Reviews 53 (2021) 3, Drug Metabolism Reviews, 53(3), 384-433
- Publication Year :
- 2021
- Publisher :
- Informa UK Limited, 2021.
-
Abstract
- This annual review is the sixth of its kind since 2016 (see references). Our objective is to explore and share articles which we deem influential and significant in the field of biotransformation and bioactivation. These fields are constantly evolving with new molecular structures and discoveries of corresponding pathways for metabolism that impact relevant drug development with respect to efficacy and safety. Based on the selected articles, we created three sections: (1) drug design, (2) metabolites and drug metabolizing enzymes, and (3) bioactivation and safety (Table 1). Unlike in years past, more biotransformation experts have joined and contributed to this effort while striving to maintain a balance of authors from academic and industry settings.[Table: see text]. ispartof: DRUG METABOLISM REVIEWS vol:53 issue:3 pages:384-433 ispartof: location:England status: published
- Subjects :
- METABOLISM
Toxicology
030226 pharmacology & pharmacy
03 medical and health sciences
nonp450 enzymes
0302 clinical medicine
p450 enzymes
Biotransformation
INTRINSIC CLEARANCE
Political science
MASS-BALANCE
Humans
Pharmacology (medical)
Pharmacology & Pharmacy
P450 Enzymes
General Pharmacology, Toxicology and Pharmaceutics
ANTISENSE OLIGONUCLEOTIDE
Toxicologie
VLAG
ARISTOLOCHIC ACID
Drug metabolism
Science & Technology
WIMEK
bioactivation
IDENTIFICATION
Year in review
IN-VITRO
NONHEPATOTOXIC DRUGS
Drug metabolizing enzymes
Drug development
030220 oncology & carcinogenesis
COVALENT BINDING DATA
Engineering ethics
biotransformation
LIVER-MICROSOMES
Life Sciences & Biomedicine
Subjects
Details
- ISSN :
- 10979883 and 03602532
- Volume :
- 53
- Database :
- OpenAIRE
- Journal :
- Drug Metabolism Reviews
- Accession number :
- edsair.doi.dedup.....9a22a3073b1b8be7c5621703d8a65f67